Abstract
Adult axons in the mammalian central nervous system do not elicit spontaneous regeneration after injury, although many affected neurons have survived the neurotrauma. However, axonal regeneration does occur under certain conditions. These conditions include: (a) modification of regrowth environment, such as supply of peripheral nerve bridges and transplantation of Schwann cells or olfactory ensheathing glia to the injury site; (b) application of neurotrophic factors at the cell soma and axon tips; (c) blockade of growth-inhibitory molecules such as Nogo-A, myelin-associated glycoprotein, and oligodendrocyte-myelin glycoprotein; (d) prevention of chondroitin-sulfate-proteoglycans-related scar tissue formation at the injury site using chondroitinase ABC; and (e) elevation of intrinsic growth potential of injured neurons via increasing intra-cellular cyclic adenosine monophosphate level. A large body of evidence suggests that these conditions achieve enhanced neuronal survival and axonal regeneration through sometimes over-lapping and sometimes distinct signal transduction mechanisms, depending on the targeted neuronal populations and intervention circumstances. This article reviews the available information on signal transduction pathways underlying neurotrophic-factor-mediated neuronal survival and neurite outgrowth/axonal regeneration. Better understanding of signaling transduction is important in helping us develop practical therapeutic approaches for encouraging neuronal survival and axonal regeneration after traumatic injury in clinical context.
Similar content being viewed by others
References
Jones L. L., Oudega M., Bunge M. B., and Tuszynski M. H. (2001) Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J. Physiol. 533, 83–89.
Cheng L., Sapieha P., Kittlerova P., Hauswirth W. W., and Di Polo A. (2002) TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 22, 3977–3986.
Schwab M. E. and Bartholdi D. (1996) Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319–370.
Carulli D., Laabs T., Geller H. M., and Fawcett J. W. (2005) Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15, 116–120.
Mansour-Robaey S., Clarke D. B., Wang Y. C., Bray G. M., and Aguayo A. J. (1994) Effects of ocular injury and administration of BDNF on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. USA 91, 1632–1636.
Peinado-Ramon P., Salvador M., Villegas-Perez M. P., and Vidal-Sanz M. (1996) Effects of axotomy and intraocular administration of NT-4, NT-3, and BDNF on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37, 489–500.
Boer G. J., Esseveldt K. E., Dijkhuizen P. A., et al. (2001) Adenoviral vector-mediated expression of NT-3 increases neuronal survival in suprachiasmatic nucleus grafts. Exp. Neurol. 169, 364–375.
Blits B., Carlstedt T. P., Ruitenberg M. J., et al. (2004) Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal AAV-mediated expression of GDNF or BDNF. Exp. Neurol. 189, 303–316.
Koeberle P. D., Gauldie J., and Ball A. K. (2004) Effects of adenoviral-mediated gene transfer of IL-10, IL-4, and TGF-β on the survival of axotomized retinal ganglion cells. Neuroscience 125, 903–920.
Cui Q., Lu Q., So K. F., and Yip H. K. (1999) CNTF, not other trophic factors, promotes axonal regeneration of axotomized retinal ganglion cells in adult hamsters. Invest. Ophthalmol. Vis. Sci. 40, 760–766.
Sawai H., Clarke D. B., Kittlerova P., Bray G. M., and Aguayo A. J. (1996) BDNF and NT-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells. J. Neurosci. 16, 3887–3894.
Segal R. A. and Greenberg M. E. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463–489.
Huang E. J. and Reichardt L. F. (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736.
Bregman B. S., Broude E., McAtee M., and Kelley M. S. (1998) Transplants and neutrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp. Neurol. 149, 13–27.
Jin Y., Fischer I., Tessler A., and Houle J. D. (2002) Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp. Neurol. 177, 265–275.
Blits B., Oudega M., Boer G. J., Bunge M. B., and Verhaagen J. (2003) AAV-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 118, 271–281.
Segal R. A. (2003) Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26, 299–330.
Shumsky J. S., Tobias C. A., Tumolo M., Long W. D., Giszter S. F., and Murray M. (2003) Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Exp. Neurol. 184, 114–130.
Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., and Parada L. F. (1991) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554–558.
Kaplan D. R., Martin-Zanca D., and Parada L. F. (1991) Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGP. Nature 350, 158–160.
Klein R., Jing S. Q., Nanduri V., O'Rourke E., and Barbacid M. (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65, 189–197.
Klein R., Nanduri V., Jing S. A., et al. (1991) The trkB tyrosine protein kinase is a receptor for BDNF and NT-3. Cell 66, 395–403.
Klein R., Lamballe F., Bryant S., and Barbacid M. (1992) The trkB tyrosine protein kinase is a receptor for NT-4. Neuron 8, 947–956.
Lamballe F., Klein R., and Barbacid M. (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for NT-3. Cell 66, 967–979.
Dechant G. (2001) Molecular interactions between neurotrophin receptors. Cell Tissue Res. 305, 229–238.
Yacoubian T. A. and Lo D. C. (2000) Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat. Neurosci. 3, 342–349.
Harrington A. W., Leiner B., Blechschimitt C., et al. (2004) Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. USA 101, 6226–6230.
Teng H. K., Teng K. K., Lee R., et al. (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455–5463.
Cui Q. and Harvey A. R. (1995) At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J. Neurosci. 15, 8143–8155.
Boyd J. G., and Gordon T. (2003) GDNF and BDNF sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp. Neurol. 183, 610–619.
Curtis R., Tonra J. R., Stark J. L., et al. (1998) Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms. Mol. Cell. Neurosci. 12, 105–118.
Spalding K. L., Cui Q., and Harvey A. R. (1998) The effects of central administration of neurotrophins or transplants of fetal tectal tissue on retinal ganglion cell survival following removal of the superior colliculus in neonatal rats. Brain Res. Dev. Brain Res. 107, 133–142.
Reynolds A. J., Bartlett S. E., and Hendry I. A. (2000) Molecular mechanisms regulating the retrograde axonal transport of neurotrophins. Brain Res. Brain Res. Rev. 33, 169–178.
von Bartheld C. S., Wang X., and Butowt R. (2001) Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol. Neurobiol. 24, 1–28.
Hetman M., Kanning K., Cavanaugh J. E., and Xia Z. (1999) Neuroprotection by BDNF is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274, 22,569–22,580.
Atwal J. K., Massie B., Miller F. D., and Kaplan D. R. (2000) The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 27, 265–277.
Klocker N., Kermer P., Weishaupt J. H., Labes M., Ankerhold R., and Bähr M. (2000) BDNF-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on PI-3K/protein kinase B signaling. J. Neurosci. 20, 6962–6967.
Brunet A., Datta S. R., and Greenberg M. E. (2001) Transcription-dependent and-independent control of neuronal survival by the PI-3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297–305.
Watson F. L., Heerssen H. M., Bhattacharyya A., Klesse L., Lin M. Z., and Segal R. A. (2001) Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4, 981–988.
Nakazawa T., Tamai M., and Mori N. (2002) BDNF prevents axotomized retinal ganglion cell death through MAPK and PI-3K signalling pathways. Invest. Ophthalmol. Vis. Sci. 43, 3319–3326.
Gao Y., Nikulina E., Mellado W., and Filbin M. T. (2003) Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J. Neurosci. 23, 11,770–11,777.
Shalizi A., Lehtinen M., Gaudilliere B., et al. (2003) Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J. Neurosci. 23, 7326–7336.
Datta S. R., Dudet H., Tao X., et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241.
Cardone M. H., Roy N., Slennicke H. R., et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 318–321.
Hanson M. G. Jr., Shen S., Wiemelt A. P., McMorris F. A., and Barres B. A. (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J. Neurosci. 18, 7361–7371.
Williams E. J., and Doherty P. (1999) Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway. Mol. Cell Neurosci. 13, 272–280.
Perron J. C. and Bixby J. L. (1999) Distinct neurite outgrowth signaling pathways converge on ERK activation. Mol. Cell. Neurosci. 13, 362–378.
Pearse D. D., Pereira F. C., Marcillo A. E., et al. (2004) cAMP and Schwann cells promote axon growth and functional recovery after spinal cord injury. Nat. Med. 10, 610–616.
Purves D., Snider W. D., and Voyvodic J. T. (1988) Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature 336, 123–128.
Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154–1162
Acheson A., Conover J. C., Fandl J. P., et al. (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374, 450–453.
Robinson M., Buj-Bello A., and Davies A. M. (1996) Paracrine interactions of BDNF involving NGF-dependent embryonic sensory neurons. Mol. Cell. Neurosci. 7, 143–151.
Yin Y., Cui Q., Li Y., et al. (2003) Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23, 2284–2293.
Yao R. and Cooper G. M. (1995) Requirement for PI-3K in the prevention of apoptosis by nerve growth factor. Science 267, 2003–2006.
Kaplan D. R. and Miller F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381–391.
Jones D. M., Tucker B. A., Rahimtula M., and Mearow K. M. (2003) The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J. Neurochem. 86, 1116–1128.
Goold R. G. and Gordon-Weeks P. R. (2005) The MAP kinase pathway is upstream of the activation of GSK3beta that enables it to phosphorylate MAP1B and contributes to the stimulation of axon growth. Mol. Cell. Neurosci. 28, 524–534
Xing J., Ginty D. D., and Greenberg M. E. (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273, 959–963.
Vaillant A. R., Mazzoni I., Tudan C., Boudreau M., Kaplan D. R., and Miller F. D. (1999) Depolarization and neurotrophins converge on the PI-3K-Akt pathway to synergistically regulate neuronal survival. J. Cell Biol. 146, 955–966.
Datta S. R., Brunet A., and Greenberg M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927.
Grewal S. S., York R. D., and Stork P. J. (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol. 9, 544–553.
Riccio A., Ahn S., Davenport C. M., Blendy J. A., and Ginty D. D. (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358–2361.
Cenni M. C., Bonfanti L., Martinou J. C., Ratto G. M., Strettoi E., and Maffei L. (1996) Longterm survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice. Eur. J. Neurosci. 8, 1735–1745.
Merry D. E. and Korsmeyer S. J. (1997) Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 20, 245–267.
Qiu D., Mao L., Kikuchi S., and Tomita M. (2004) Sustained MAPK activation is dependent on continual NGF receptor regeneration. Dev. Growth Differ. 46, 393–403.
Trivedi N., Marsh P., Goold R. G., Wood-Kaczmar A., and Gordon-Weeks P. R. (2005) Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons. J. Cell Sci. 118, 993–1005.
Bonni A., Brunet A., West A. E., Datta S. R., Takasu M. A., and Greenberg M. E. (1999) Cell survival promoted by the Ras-MAPK signalling pathway by transcription-dependent and-independent mechanism. Science 286, 1358–1362.
Goldberg J. L. and Barres B. A. (2000) The relationship between neuronal survival and regeneration. Annu. Rev. Neurosci. 23, 579–612.
Grill R. J., Blesch A., and Tuszynski M. H. (1997) Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148, 444–452.
Bloch J., Fine E. G., Bouche N., Zurn A. D., and Aebischer P. (2001) NGF- and NT-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp. Neurol. 172, 425–432.
Romero M. I., Rangappa N., Garry M. G., and Smith G. M. (2001) Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J. Neurosci. 21, 8408–8416.
Hagg T., Vahlsing H. L., Manthorpe M., and Varon S. (1990) NGF infusion into the denervated adult rat hippocampal formation promotes its cholinergic reinnervation. J. Neurosci. 10, 3087–3092.
Ramirez J. J., Caldwell J. L., Majure M., et al. (2003) AAV expressing NGF enhances cholinergic axonal sprouting after cortical injury in rats. J. Neurosci. 23, 2797–2803.
Yamashita T., Tucker K. L., and Barde Y. A. (1999) neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24, 585–593.
Kimpinski K. and Mearow K. (2001) Neurite growth promotion by NGF and IGF-1 in cultured adult sensory neurons: role of PI-3K and MAPK. J. Neurosci. Res. 63, 486–499.
Markus A., Zhong J., and Snider W. D. (2002) Raf and Akt mediate distinct aspects of sensory axon growth. Neuron 35, 65–76.
Hofer M. M. and Barde Y. A. (1988) BDNF prevents neuronal death in vivo. Nature 331, 261–262.
Alderson R. F., Alterman A. L., Barde Y. A., and Lindsay R. M. (1990) BDNF increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5, 297–306.
Hyman C., Hofer M., Barde Y. A., et al. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia, nigra. Nature 350, 230–232.
Kobayashi N. R., Fan D. P., Giehl K. M., Bedard A. M., Wiegand S. J., and Tetzlaff W. (1997) BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talphal-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17, 9583–9595.
Cui Q., Yip H. K., Zhao R. C., So K. F., and Harvey A. R. (2003) Intraocular elevation of cyclic AMP potentiates CNTF-induced regeneration of adult rat retinal ganglion cell axons. Mol. Cell. Neurosci. 22, 49–61.
Ruitenberg M. J., Plant G. W., Hamers F. P., et al. (2003) Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J. Neurosci. 23, 7045–7058.
Skaper S. D., Floreani M., Negro A., Facci L., and Giusti P. (1998) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of PI-3K and MAPK pathway. J. Neurochem. 70, 1859–1868.
Dolcet X., Egea J., Soler R. M., Martin-Zanca D., and Comella J. X. (1999) Activation of PI-3K, but not ERK, is necessary to mediate BDNF-induced motoneuron survival. J. Neurochem. 73, 521–531.
Yuen E. C. and Mobley W. C. (1999) Early BDNF, NT-3, and NT-4 signaling events. Exp. Neurol. 159, 297–308.
Kashiwagi F., Kashiwagi K., Iizuka Y., and Tsukahara S. (2000) Effects of BDNF and NT-4 on isolated cultured retinal ganglion cells: evaluation by flow cytometry. Invest. Ophthalmol. Vis. Sci. 41, 2373–2377.
Bosco A. and Linden R. (1999) BDNF and NT-4 differentially modulate neurite outgrowth in developing retinal ganglion cells. J. Neurosci. Res. 57, 759–769.
Zhi Y., Lu Q., Zhang C. W., Yip H. K., So K. F., and Cui Q. (2005) Different optic nerve injury sites result in differential cellular responses of retinal ganglion cell to BDNF but not NT-4/5. Brain Res., 1047, 224–232.
Fan G., Egles C., Sun Y., et al. (2000) Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activities. Nat. Neurosci. 3, 350–357.
Williams G., Williams E. J., Maison P., Pangalos M. N., Walsh F. S., and Doherty P. (2005) Overcoming the inhibitors of myelin with a novel neurotrophin strategy. J. Biol. Chem. 280, 5862–5869.
Gao Y., Deng K., Hou J., et al. (2004) Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron 44, 609–621.
Klocker N., Jung M., Stuermer C. A., and Bähr M. (2001) BDNF increases the number of axotomized rat retinal ganglion cells expressing GAP-43, L1, and TAG-1 mRNA—a supportive role for nitric oxide?. Neurobiol. Dis. 8, 103–113.
Aigner L., Arber S., Hapfhammer J. P., et al. (1995) Overexpression of the neural growthassociated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83, 269–278.
Meiri K. F., Saffell J. L., Walsh F. S., and Doherty P. (1998) Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. J. Neurosci. 18, 10,429–10,437.
Gianola S. and Rossi F. (2004) GAP-43 overexpression in adult mouse Purkinje cells overrides myelin-derived inhibition of neurite growth. Eur. J. Neurosci. 19, 819–830.
Liot G., Gabriel C., Cacquevel M., et al. (2004) Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Exp. Neurol. 187, 38–46.
Ventimiglia R., Mather P. E., Jones B. E., and Lindsay R. M. (1995) The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7, 213–222.
Giehl K. M. and Tetzlaff W. (1996) BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur. J. Neurosci. 8, 1167–1175.
Novikova L. N., Novikov L. N., and Kellerth J. O. (2000) Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur. J. Neurosci. 12, 776–780.
Novikova L. N., Novikov L. N., and Kellerth J. O. (2000) BDNF abolishes the survival effect of NT-3 in axotomized Clarke neurons of adult rats. J. Comp. Neurol. 428, 671–680.
Giehl K. M., Rohrig S., Bonate H., et al. (2001) Endogenous BDNF and NT-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J. Neurosci. 21, 3492–3502.
Aletsee C., Beros A., Mullen L., et al. (2001) Ras/MEK but not p38 signaling mediates NT-3-induced neurite extension from spiral ganglion neurons. J. Assoc. Res. Otolaryngol. 2, 377–387.
Wiklund P., Ekstrom P. A., and Edstrom A. (2002) MAPK inhibition reveals differences in signalling pathways activated by NT-3 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons. J. Neurosci. Res. 67, 62–68.
Hermann D. M., Kilic E., Kugler S., Isenmann S., and Bähr M. (2001) Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol. Dis. 8, 655–666.
van Adel B. A., Kostic C., Deglon N., Ball A. K., and Arsenijevic Y. (2003) Delivery of CNTF via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. Hum. Gene. Ther. 14, 103–115.
Ji J. Z., Elyaman W., Yip H. K., et al. (2004) CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur. J. Neurosci. 19, 265–272.
Jo S. A., Wang E., and Benowitz L. I. (1999) CNTF is an axogenesis factor for retinal ganglion cells. Neuroscience 80, 579–591.
Park K., Luo J. M., Hisheh S., Harvey A. R., and Cui Q. (2004) Cellular mechanisms associated with spontaneous and CNTF-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J. Neurosci. 24, 10,806–10,815.
Hu Y., Leaver S. G., Plant G. W., et al. (2005) Peripheral nerve constructs genetically engineered to express CNTF enhance the regeneration of adult CNS axons. Mol. Ther. 11, 906–915.
Ip NY and Yancopoulos G. D. (1992) CNTF and its receptor complex. Prog. Growth Factor Res. 4, 139–155.
Davis S., Aldrich T. H., Stahl N., et al. (1993) LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260, 1805–1808.
Ip NY, McClain J., Barrezueta N. X., et al. (1993) The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron 10, 89–102.
Ip NY and Yancopoulos G. D. (1996) The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19, 491–515.
MacLennan A. J., Neitzel K. L., Devlin B. K., et al. (2000) In vivo localization and characterization of functional CNTFs which utilize JAK-STAT signaling. Neuroscience 99, 761–772.
Peterson W. M., Wang Q., Tzekova R., and Wiegand S. J. (2000). CNTF and stress activate the Jak-STAT pathway in retinal neurons and glia. J. Neurosci. 20, 4081–4090.
Alonzi T., Middleton G., Wyatt S., et al. (2001) Role of STAT3 and PI3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol. Cell. Neurosci. 18, 270–282.
Dolcet X., Soler R. M., Gould T. W., Egea J., Oppenheim R. W., and Comella J. X. (2001) Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the PI-3K pathway. Mol. Cell. Neurosci. 18, 619–631.
Goldberg J. L., Espinosa J. S., Xu Y., Davidson N., Kovasc G. T., and Barres B. A. (2002) Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signalling and electrical activity. Neuron 33, 689–702.
Boucher M. J., Morisset J., Vachon P. H., Reed J. C., Laine J., and Rivard N. (2000) MEK/ERK signalling pathway regulates the expression of Bcl-2. Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell. Biochem. 79, 355–369.
Jin K., Mao X. O., Zhu Y., and Greenberg D. A. (2002) MEK and ERK protect hypoxia cortical neurons via phosphorylation of Bad. J. Neurochem. 80, 119–125.
Darnell J. E. Jr., Kerr I. M., and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421.
Lutticken C., Negenka U. M., Yuan J., et al. (1994) Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263, 89–92.
Stahl N., Boulton T. G., Farruggalla T., et al. (1994) Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263, 92–95.
Ihle J. N. (1996) STATs: signal transducers and activators of transcription. Cell 84, 331–334.
Vignais M. L., Sadowski H. B., Watling D., Rogers N. C., and Gilman M. (1996) Plateletderived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell Biol. 16, 1759–1769.
Schweizer U., Gunnersen J., Karch C., et al. (2002) Conditional gene ablation of Stat3 reveals differential, signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol. 156, 287–297.
Boyd Z. S., Kriatchko A., Yang J., Agarwal N., Wax M. B., and Patil R. V. (2003) IL-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest. Ophthalmol. Vis. Sci. 44, 5206–5211.
Fuhrmann S., Kirsch M., Heller S., Rohrer H., and Hofmann H. D. (1998) Differential regulation of ciliary, neurotrophic factor receptor-alpha expression in all major neuronal cell classes during development of the chick retina. J. Comp. Neurol. 400 244–254.
Cowley S., Paterson H., Kemp P., and Marshall C. J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841–852.
Miura T., Tanaka S., Seichi A., et al. (2000) Partial functional recovery of paraplegic rat by adenovirus-mediated gene delivery of constitutively active MEK1. Exp. Neurol. 166, 115–126.
Namikawa K., Honma M., Abe K., et al. (2000) Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20, 2875–2886.
Desbarats J., Birge R. B., Mimouni-Rongy M., Weinstein D. E., Palerme J. S., and Newell M. K. (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118–125.
Mazzoni I.E., Said F. A., Aloyz R., Miller F. D., and Kaplan D. (1999) Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J. Neurosci. 19, 9716–9727.
Alessandrini A., Namura S., Moskowitz M. A., and Bonventre J. V. (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 12,866–12,869.
Lin L. F., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132.
Airaksinen M. S. and Saarma M. (2002) the GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383–394.
Arenas E., Trupp M., Akerud P., and Ibanes C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465–1473.
Schmeer C., Straten G., Kugler S., Gravel C., Bähr M., and Isenmann S. (2002) Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of GDNF in vivo. Eur. J. Neurosci. 15, 637–643.
Cheng C., Huang S. S., Lin S. M., et al. (2003) The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats. Brain Res. 1033, 28–33.
Iannotti C., Li H., Yan P., Lu X., Wirthlin L., and Xu X. M. (2003) GDNF-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp. Neurol. 183, 379–393.
Jin G., Omori N., Li F., et al. (2003) Protection against ischemic brain damage by GDNF affecting cell survival and death signals. Neurol. Res. 25, 249–253.
Ishikawa K., Takano M., Matsumoto N., et al. (2005) Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther. 12, 289–298.
Lindqvist N., Peinado-Ramónn P., Vidal-Sanz M., and Hallböök F. (2004) GDNF, Ret, GFRα1 and 2 in the adult rat retino-tectal system after optic nerve transection. Exp. Neurol. 187, 487–499.
Henderson C. E., Phillips H. S., Pollock R. P., et al. (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062–1064.
Bohn M. C. (2004) Motoneurons crave GDNF. Exp. Neurol. 190, 263–275.
Sariola H. and Saarma M. (2003). Novel functions and signalling pathways for GDNF. J. Cell Sci. 116, 3855–3862.
Paratcha G., Ledda F., and Ibanes C. F. (2003). The neural cell adhesion molecule NCAM is an alternative signalling receptor for GDNF family ligands. Cell 113, 867–879.
Soler R. M., dolcet X., Encinas M., Egea J., Bayascas J. R., and Comella J. X. (1999) Receptors of the GDNF family of neurotrophic factors signal cell survival through the PI-3K pathway in spinal cord motoneurons. J. Neurosci. 19, 9160–9169.
Trupp M., Scott R., Whittemore S. R., and Ibanez C. F. (1999) Ret-dependent and-independent mechanisms of GDNF signalling in neuronal cells. J. Biol. Chem. 274, 20,885–20,894.
Hayashi H., Ichihara M., Iwashita T., et al. (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by GDNF. Oncogene 19, 4469–4475.
Mograbi B., Bocciardi R., Bourget I., et al. (2001) GDNF-stimulated PI-3K and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J. Biol. Chem. 276, 45,307–45,319.
Storer P. D., Dolbeare D., and Houle J. D. (2003) Treatment of chronically injured spinal cord with neurotrophic factors stimulates betaII-tubulin and GAP-43 expression in rubrospinal tract neurons. J. Neurosci. Res. 74, 502–511.
Mark R.J., Fuson K. S., Keane-Lazar K., and May P. C. (1999) FGF-8 protects cultured rat hippocampal neurons from oxidative insult. Brain Res. 830, 88–93.
Alzheimer C. and Werner S. (2002) Fibroblast growth factors and neuroprotection. Adv. Exp. Med. Biol. 513, 335–351.
Walicke P., Cowan W. M., Ueno N., Baird A., and Guillemin R. (1986) FGF promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. USA 83, 3012–3016.
Anderson K. J., Dam D., Lee S., and Cotman C. W. (1988) Basic FGF prevents death of lesioned cholinergic neurons in vivo. Nature 332, 360,361.
Williams E. J., Furness J., Walsh F. S., and Doherty P. (1994) Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13, 583–594.
Lin H. Y., Xu J., Ornitz D. M., Halegoua S., and Hayman M. J. (1996) The FGF receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF. J. Neurosci. 16, 4579–4587.
Fontaine V., Kinkl N., Sahel J., Dreyfus H., and Hicks D. (1998) Survival of purified rat photoreceptors in vitro is stimulated directly by FGF-2. J. Neurosci. 18, 9662–9672.
Kuzis K., Coffin J. D., and Eckenstein F. P. (1999) Time course and age dependence of motor neuron death following facial nerve crush injury: role of fibroblast growth factor. Exp. Neurol. 157, 77–87.
Lau D., McGee L. H., Zhou S., et al. (2000) Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest. Ophthalmol. Vis. Sci. 41, 3622–3633.
Sapieha P. S., Peltier M., Rendahl K. G., Manning W. C., and Di Polo A. (2003) FGF-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol. Cell. Neurosci. 24, 656–672.
Tanabe K., Bonilla I., Winkles J. A., and Strittmatter S. M. (2003) Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J. Neurosci. 23, 9675–9686.
Williams E. J., Furness J., Walsh F. S., and Doherty P. (1994) Characterisation of the second messenger pathway underlying neurite outgrowth stimulated by FGF. Development 120, 1685–1693.
Creuzet C., Loeb J., and Barbin G. (1995) FGFs stimulate protein tyrosine phosphorylation and MAPK activity in primary cultures of hippocampal neurons. J. Neurochem. 64, 1541–1547.
Desire L., Courtois Y., and Jeanny J. C. (2000) Endogenous and exogenous FGF 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-x(L) and bcl-2 expression through a FGF receptor 1- and ERK-dependent pathway. J. Neurochem. 75, 151–163.
Miho Y., Kouroku Y., Fujita E., et al. (1999) bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation. Cell Death Differ. 6, 463–470.
Renaud F., Desset S., Oliver L., et al. (1996) The neurotrophic activity of fibroblast growth factor 1 (FGF1) depends on endogenous FGF1 expression and is independent of the MAPK cascade pathway. J. Biol. Chem. 271, 2801–2811.
Saffell J. L., Williams E. J., Mason I. J., Walsh F. S., and Doherty P. (1997) Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs. Neuron 18, 231–242.
Viollet C. and Doherty P. (1997) CAMs and the FGF receptor: an interacting role in axonal growth. Cell Tissue Res. 290, 451–455.
Williams E. J., Walsh F. S., and Doherty P. (2003) The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J. Cell Biol. 160, 481–486.
Rydel R. E. and Greene L. A. (1988). cAMP analogues promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85, 1257–1261.
Song H. J. and Poo M. M. (1999). Signal transduction underlying growth cone guidance by diffusible factors. Curr. Opin. Neurobiol. 9, 355–363.
Ming G., Song H. J., Berninger B., Holt C. E., Tessier-Lavigne M., and Poo M. M. (1997) cAMP-dependent growth cone guidance by netrin-1. Neuron 19, 1225–1235.
Nishiyama M., Hoshino A., Tsai L., et al. (2003) Cyclic AMP/GMP-dependent modulation of Ca channels sets the polarity of nerve growthcone turning. Nature 423, 990–995.
Kao H. T., Song H. J., Porton B., et al. (2002) A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat. Neurosci. 5, 431–437.
Song H., Ming G. L., and Poo M. M. (1997) cAMP-induced switch in turning direction of nerve growth cones. Nature 388, 275–279.
Cai D., Shen Y., De Bellard M., Tang S., and Filbin M. T. (1999) Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 22, 89–101.
Cai D., Deng K., Mellado W., Lee J., Ratan R. R., and Filbin M. T. (2002) Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron 35, 711–719.
Meyer-Franke A., Kaplan M. R., Pfrieger F. W., and Barres B. A. (1995) Characterization of the signalling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15, 805–819.
Meyer-Franke A., Wilkinson G. A., Kruttgen A., et al. (1998) Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 21, 681–693.
Shen S., Wiemelt A. P., McMorris F. A., and Barres B. A. (1999) Retinal ganglion cells lose trophic responsiveness after axotomy. Neuron 23, 285–295.
Finkbeiner S. and Greenberg M. E. (1998) Calcium channel regulated neuronal gene expression. J. Neurobiol. 37, 171–189.
Tao X., Finkbeiner S., Arnold D. B., Shaywitz A. J., and Greenberg M. E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726.
Finkbeiner S. (2000) Calcium regulation of the BDNF gene. Cell Mol. Life Sci. 57, 394–401.
Deogracias R., Espliguero G., Iglesias T., and Rodriguez-Pena A. (2004) Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol. Cell. Neurosci. 26, 470–480.
Poser S., Impey S., Xia Z., and Storm D. R. (2003) BDNF protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J. Neurosci. 23, 4420–4427.
Hansen M. R., Zha X. M., Bok J., and Green S. H. (2001) Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J. Neurosci. 21, 2256–2267.
Gallo G., Ernst A. F., McLoon S. C., and Letourneau P. C. (2002) Transient PKA activity is required for initiation but not maintenance of BDNF-mediated protection from nitric oxide-induced growth-cone collapse. J. Neurosci. 22, 5016–5023.
Watanabe M., Tokita Y., Kato M., and Fukuda Y. (2003) Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized β ganglion cells in cat retina. Neuroscience 116, 733–742.
Cai D., Qiu J., Cao Z., McAtee M., Bregman B. S., and Filbin M. T. (2001) Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J. Neurosci. 21, 4731–4739.
Neumann S., Bradke F., Tessier-Lavigne M., and Basbaum A. I. (2002) Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 34, 885–893.
Qiu J., Cai D., Dai H., et al. (2002) Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 34, 895–903.
Nikulina E., Tidwell J. L., Dai H. N., Bregman B. S. and Filbin M. T. (2004) The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. USA 101, 8786–8790.
Monsul N. T., Geisendorfer A. R., Han P. J., et al. (2004) Intraocular injection of dibutyryl cyclic AMP promotes axon regeneration in rat optic nerve. Exp. Neurol. 186, 124–133.
Lu P., Yang H., Jones L. L., Filbin M. T., and Tuszynski M. H. (2004) Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24, 6402–6409.
Li M., Wang X., Meintzer M. K., Laessig T., Birnbaum M. J., and Heidenreich K. A. (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol. Cell Biol. 20, 9356–9363.
Esch F., Lin K. I., Hills A., et al. (1998) Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J. Neurosci. 18, 4083–4095.
Kaminska B., Kaczmarek L., and Grzelakowska-Sztabert B. (1992) Inhibitors of polyamine biosynthesis affect the expression of genes encoding cytoskeletal proteins. FEBS Lett. 304, 198–200.
Williams K., Zappia A. M., Pritchett D. B., Shen Y. M., and Molinoff P. B. (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol. 45, 803–809.
Kashiwagi K., Pahk A. J., Masuko T., Igarashi K., and Williams K. (1997) Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and poreforming regions of NR1 and NR2 subunits. Mol. Pharmacol. 52, 701–713.
Williams K. (1997) Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9, 1–13.
Wang K. C., Kim J. A., Sivasankaran R., Segal R., and He Z. (2002) p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78.
Wong S. T., Henley J. R., Kanning K. C., Huang K. H., Bothwell M., and Poo M. M. (2002) A p75(NTR) and Nogo receptor complex mediates repulsive signaling by MAG. Nat. Neurosci. 5, 1302–1308.
Mi S., Lee X., Shao Z., et al. (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 7, 221–228.
Luo L. (2000) Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1, 173–180.
Niederost B., Oertle T., Fritsche J., McKinney R. A., and Bandtlow C. E. (2002) Nogo-A and MAG mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22, 10,368–10,376.
Ahmed Z., Dent R. G., Suggate G. L. et al. (2005) Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A. Mol. Cell. Neurosci. 28, 509–523.
Bryan B., Cai Y., Wrighton K., Wu G., Feng X. H., and Liu M. (2005) Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Lett. 579, 1015–1019.
Lehmann M., Fournier A. E., Selles-Navarro I., et al. (1999). Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19, 7537–7547.
Fournier A. E. and McKerracher L. (1997) Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of BDNF. J. Neurosci. 17, 4623–4632.
Mason M. R., Campbell G., Caroni P., Anderson P. N., and Lieberman A. R. (2000) Overexpression of GAP-43 on thalamic projection neurons of transgenic mice does not enable them to regenerate axons-through peripheral nerve grafts. Exp. Neurol. 165, 143–152.
Wewetzer K., Grothe C., and Claus P. (2001) In vitro expression and regulation of ciliary neurotrophic factor and its alpha receptor subunit in neonatal rat olfactory ensheathing cells. Neurosci. Lett. 306, 165–168.
Caroni P. and Schwab M. E. (1988) Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1, 85–96.
McKerracher L., David S., Jackson D. L., Kottis V., Dunn R. J., and Braun P. E. (1994) Identification of MAG as a major myelin-derived inhibitor of neurite growth. Neuron 13, 805–811.
Mukhopadhyay G., Doherty P., Walsh F. S., Crocker P. R., and Filbin M. T. (1994) A novel role for MAG as an inhibitor of axonal regeneration. Neuron 13, 757–767.
Kottis V., Thibault P., Mikol D., et al. (2002) Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82, 1566–1569.
Bregman B. S., Kunkel-Bagden E., Schnell L., Dai H. N., Gao D., and Schwab M. E. (1995) Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378, 498–501.
Z'Graggen W. J., Metz G. A., Kartje G. L., Thallmair M., and Schwab M. E. (1998) Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J. Neurosci. 18, 4744–4757.
Hunt D., Mason M. R., Campbell G., Coffin R., and Anderson P. N. (2002) Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol. Cell. Neurosci. 20, 537–552.
Bähr M. and Schwab M. E. (1996) Antibody that neutralizes myelin-associated inhibitors of axon growth does not interfere with recognition of target-specific guidance information by rat retinal axons. J. Neurobiol. 30, 281–292.
Weibel D., Cadelli D., and Schwab M. E. (1994) Regeneration of lesioned rat optic nerve fibers is improved after neutralization of myelin-associated neurite growth inhibitors. Brain Res. 642, 259–266.
Schnell L., Schneider R., Kolbeck R., Barde Y. A., and Schwab M. E. (1994) NT-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367, 170–173.
Chen M. S., Huber A. B., van der Haar M. E., et al. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434–439.
GrandPre T., Nakamura F., Vartanian T., and Strittmatter S. M. (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439–444.
Fournier A. E., GrandPre T., and Strittmatter S. M. (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409, 341–346.
Prinjha R., Moore S. E., Vinson M., et al. (2000) Inhibitor of neurite outgrowth in humans. Nature 403, 383–384.
Yamaguchi Y., Katoh H., Yasui H., Mori K., and Negishi M. (2001) RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway. J. Biol. Chem. 276, 18,977–18,983.
Domeniconi M., Cao Z., Spencer T., et al. (2002) Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35, 283–290.
Liu B. P., Fournier A., GrandPre T., and Strittmatter S. M. (2002) MAG as a functional ligand for the Nogo-66 receptor. Science 297, 1190–1193.
Wang K. C., Koprivica V., Kim J. A., et al. (2002) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417, 941–944.
Yamashita T., Higuchi H., and Tohyama M. (2002) The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157, 565–570.
Fournier A. E., Takizawa B. T., and Strittmatter S. M. (2003) Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23, 1416–1423.
Woolf C. J. (2002) No Nogo: now where to go? Neuron 38, 153–156.
Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W. D., and McKerracher L. (2002) Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570–6577.
Mizuno T., Yamashita T., and Tohyama M. (2004) Chimaerins act downstream from neurotrophins in overcoming the inhibition of neurite outgrowth produced by myelin-associated glycoprotein. J. Neurochem. 91, 395–403.
Bareyre F. M., Haudenschild B., and Schwab M. E. (2002) Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J. Neurosci. 22, 7097–7110.
Thallmair M., Metz G. A., Z'Graggen W. J., Raineteau O., Kartje G. L., and Schwab M. E. (1998) Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1, 124–131.
Merkler D., Metz G. A., Raineteau O., Dietz V., Schwab M. E., and Fouad K. (2001) Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 21, 3665–3673.
Oudega M., Rosano C., Sadi D., Wood P. M., Schwab M. E., and Hagg T. (2000) Neutralizin antibodies against neurite growth inhibitor NI-35/250 do not promote regeneration of sensory axons in the adult rat spinal cord. Neuroscience 100, 873–883.
Kim J. E., Li S., GrandPré T., Qiu D., and Strittmatter S. M. (2003) Axon Regeneration in Young Adult Mice Lacking Nogo-A/B. Neuron 38, 187–199.
Simonen M., Pedersen V., Weinmann O., et al. (2003) Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38, 201–211.
Zheng B., Ho C., Li S., Keirstead H., Steward O., and Tessier-Lavigne M. (2003) Lack of Enhanced Spinal Regeneration in Nogo-Dificient Mice. Neuron 38, 213–224.
GrandPre T., Li S., and Strittmatter S. M. (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417, 547–551.
Davies S. J., Fitch M. T., Memberg S. P., Hall A. K., Raisman G., and Silver J. (1997) Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390, 680–683.
Davies S. J., Goucher D. R., Doller C., and Silver J. (1999) Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19, 5810–5822.
Fawcett J. W. (1997) Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell Tissue Res. 290, 371–377.
David S. and Lacroix S. (2003) Molecular approaches to spinal cord repair. Annu. Rev. Neurosci. 26, 411–440.
Moon L. D., Asher R. A., Rhodes K. E., and Fawcett J. W. (2001) Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465–466.
Chao M. V. (1994) The p75 neurotrophin receptor. J. Neurobiol. 25, 1373–1385.
Davies A. M., Lee K. F., and Jaenisch R. (1993) p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 11, 565–574.
Hantzopoulos P. A., Suri C., Glass D. J., Goldfarb M. P., and Yancopøulos G. D. (1994) The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 13, 187–201.
Bible M., Hoppe E., and Barde Y. A. (1999) Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR EMBO J. 186, 616–622.
Mischel P. S., Smith S. G., Vining E. R., Valletta J. S., Mobley W. C., and Reichardt L. F. (2001) The extracellular domain of p75NTR is necessary to inhibit NT-3 signaling through receptors trk. J. Biol. Chem. 276, 11,294–11,301.
Naumann T., Casademunt E., Hollerbach E., et al. (2002) Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J. Neurosci. 22, 2409–2418.
von Schack D., Casademunt E., Schweigreiter R., Meyer M., Bibel M., and Dechant G. (2001) Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat. Neurosci. 4, 977–978.
Schweigreiter R., Walmsley A. R., Neiderost B., et al. (2004) Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. Mol. Cell. Neurosci. 27, 163–174.
Yamashita T. and Tohyama M. (2003) The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6, 461–467.
Walsh G. S., Krol K. M., Crutcher K. A., and Kawaja M. D. (1999) Enhanced neurotrophin-induced axon growth in myelinated portions of the CNS in mice lacking the p75NTR. J. Neurosci. 19, 4155–4168.
Hannila S. S. and Kawaja M. D. (2005) NGF-mediated collateral sprouting of central sensory axons into deafferentated regions of the dorsal horn is enhanced in the absence of the p75NTR. J. Comp. Neurol. 486, 331–343.
Gschwendtner A., Liu Z., Hucho T., et al. (2003) Regulation, cellular localization, and function of the p75 neurotrophin receptor (p75NTR) during the regeneration of facial motoneurons. Mol. Cell. Neurosci. 24, 307–322.
Hempstead B. L. (2002) The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260–267.
Park J. B., Yiu G., Komeko S., et al. (2005) A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors Neuron 45, 345–351.
Shao Z., Browning J. L., Lee X., et al. (2005) TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45, 353–359.
Li Y., Field P. M., and Raisman G. (1997) Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2002.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cui, Q. Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration. Mol Neurobiol 33, 155–179 (2006). https://doi.org/10.1385/MN:33:2:155
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:33:2:155